![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 0.11% | 4.65 | 4.41 | 4.89 | 4.53 | 4.51 | 4.53 | 241,784 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.51 | 9.35M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/7/2020 09:27 | Fatgreek good find. This part is significant: .The 28-day overall mortality was significantly lower in the IFN than the control group (19% vs. 43.6% respectively, p= 0.015). Early administration significantly reduced mortality (OR=13.5; 95% CI: 1.5-118). If SNG achieves similar outcomes then the application will save lives, money, health service resources and reduce the appalling trauma that severe COVID infection inflict on patients at the time, let alone the side effects which are emerging. | ![]() grosstonnage | |
14/7/2020 09:19 | Aah, here they come. Just to kill any upward momentum. | ![]() wetdream | |
14/7/2020 08:42 | "adding it to the national protocol significantly increased discharge rate on day 14 and decreased 28-day mortality."https://a | ![]() fatgreek | |
14/7/2020 08:36 | on the buying side spread 36 v 38p +3.50p | master rsi | |
14/7/2020 08:22 | Ok, where’s the early morning sells? | ![]() wetdream |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions